Literature DB >> 29165511

[Cystoisospora belli infection in HIV patients: Analysis of cases with different clinical evolution].

Heber Silva-Díaz1, Darwin Fernández-Valverde1, Gustavo Hernández-Córdova2, Virgilio E Failoc-Rojas3.   

Abstract

INTRODUCTION: Cystoisospora belli infection is one of the most important causes of watery diarrhea in patients with HIV and causes high rates of morbidity and mortality.
METHODS: A retrospective study was conducted in patients with HIV and diarrhea by C. belli. Clinical and laboratory characteristics were collected by analyzing clinical records.
RESULTS: Four had recurrent diarrhea despite receiving secondary prophylaxis with cotrimoxazole and specific treatment, two of which had a good viral and immunological response to highly active antiretroviral therapy (HAART) at the time of diagnosis and antiparasitic treatment. While the remaining three did not receive prophylaxis, neither did HAART (two of them), but they responded well to treatment.
CONCLUSIONS: C. belli is an important cause of diarrhea in HIV patients on HAART and prophylaxis, being able to have different clinical evolution. We suggest that persistent infection may be due to drug failure by intrinsic or extrinsic to the parasite causes, or to defects in restoration of the intestinal immune system, or both.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29165511     DOI: 10.4067/s0716-10182017000400347

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  2 in total

1.  Cystoisospora belli, liver disease and hypothesis on the life cycle.

Authors:  Jorge Néstor Velásquez; Cristina Beatriz Etchart; Osvaldo Germán Astudillo; Agustín Víctor Chertcoff; María Laura Pantano; Silvana Carnevale
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

2.  Role of the Pedodentist in the diagnosis of human immunodeficiency virus infection in children.

Authors:  Jalila Hammouti; Bouchra Taleb; Hakima Chhoul; Hind Ramdi
Journal:  Tunis Med       Date:  2022 Janvier
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.